89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding 89bio, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 50 | 69 | +19 |
| Shares | 17.3M | 17.1M | −237.3K (−1.4%) |
| Value | $226.1M | $64.3M | −$161.8M (−71.5%) |
New holders (23)
Institutions that held 89bio, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (4)
Institutions that held 89bio, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Eventide Asset Management, LLC | 716,670 | $9.37M |
| Candriam Luxembourg S.C.A. | 488,197 | $6.38M |
| Parkman Healthcare Partners LLC | 152,098 | $1.99M |
| Altium Capital Management LP | 148,000 | $1.93M |